Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 406

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 406
---
 those generally imposed on members of the combined company’s audit committee and the combined company’s board of directors. The combined company’s audit committee will be directly responsible for, among other things:

| • | the combined company’s accounting and financial reporting processes, including its financial statement audits and the integrity of its financial statements; |

| • | the combined company’s compliance with legal and regulatory requirements; |

| • | reviewing and approving related person transactions; |

| • | selecting and hiring the combined company’s registered independent public accounting firm; |

| • | the qualifications, independence and performance of the combined company’s independent auditors; and |

| • | the preparation of the audit committee report to be included in the combined company’s annual proxy statement. |

Compensation Committee Following the completion of the Merger, the members of the combined company’s compensation committee are expected to be Messrs. Davis and Malamut, each of whom qualifies as an independent director, as defined under applicable The NYSE American listing rules and also meets the additional, heightened independence criteria applicable to members of the compensation committee. Mr. Davis is expected to chair the compensation committee. The combined company’s compensation committee will be responsible for, among other things:

| • | evaluating, recommending, approving and reviewing executive officer and director compensation arrangements, plans, policies and programs; |

| • | administering our cash-based and equity-based compensation plans; and |

| • | making recommendations to the combined company’s board of directors regarding any other board of director responsibilities relating to executive compensation. |

Nominating and Corporate Governance Committee Following the completion of the Merger, the members of the combined company’s nominating and corporate governance committee are expected to be Messrs. Baxter and Pauls, each of whom qualifies as an independent director, as defined under applicable The NYSE American listing rules. Mr. Pauls is expected to chair the nominating and corporate governance committee.

229

TABLE OF CONTENTS

The combined company’s nominating and corporate governance committee will be responsible for, among other things:

| • | identifying, considering and recommending candidates for membership on the combined company’s board of directors; |

| • | overseeing the process of evaluating the performance of the combined company’s board of directors; and |

| • | advising the combined company’s board of directors on other corporate governance matters. |

Code of Business Conduct and Ethics Following the completion of the Merger, the combined company will adopt a written code of business conduct and ethics that will apply to all of the combined company’s directors, officers